IN recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave the world Ozempic, lost a quarter of its market value in a day after it cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback